Overview
Announcements

Ordinary Index Rebalancing in the Solactive China Biotech Innovation Index | May 2022

In the ordinary rebalance the following composition will be implemented effective open 16.05.2022:

3SBIO INC
ALPHAMAB ONCOLOGY
ANJOY FOODS GROUP CO LTD
ASCENTAGE PHARMA GROUP INTERNATIONAL
BEIJING BOHUI INNOVATION B-A
BEIJING SL PHARMACEUTICAL -A
BEIJING TIANTAN BIOLOGICAL-A
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO LTD
BERRY GENOMICS CO LTD-A
BGI GENOMICS CO LTD-A
CHANGCHUN HIGH & NEW TECH-A
CHENGDU KANGHUA BIOLOGICAL PRODUCTS CO LTD
CHONGQING ZHIFEI BIOLOGICA-A
CSPC PHARMACEUTICAL GROUP LTD
DAAN GENE CO LTD-A
GENSCRIPT BIOTECH CORP
GETEIN BIOTECH INC-A
GUANGDONG HYBRIBIO BIOTECH-A
GUANGZHOU WONDFO BIOTECH C-A
HEBEI CHANGSHAN BIOCHEMICA-A
HUALAN BIOLOGICAL ENGINEER-A
JOINN LABORATORIES CHINA CO LTD
JW CAYMAN THERAPEUTICS CO LT
KINTOR PHARMACEUTICAL LTD
PHARMABLOCK SCIENCES NANJI-A
SHANGHAI HAOHAI BIOLOGICAL-A
SHANGHAI RAAS BLOOD PRODUC-A
SHENZHEN KANGTAI BIOLOGICA-A
SHENZHEN NEPTUNUS BIOENG-A
SICHUAN KELUN PHARMACEUTIC-A
VIVA BIOTECH HOLDINGS
WALVAX BIOTECHNOLOGY CO-A
WUXI BIOLOGICS CAYMAN INC
ZAI LAB LTD